The laboratory of the future, according to Cellaven
What if researchers spent less time on repetitive tasks and more time generating new knowledge? That is the vision behind Cellaven, a Dijon- ...
Find out more
What if researchers spent less time on repetitive tasks and more time generating new knowledge? That is the vision behind Cellaven, a Dijon- ...
Find out more
The French biotech company ScreenCell is developing an innovative blood filtration technology designed to improve the monitoring of solid tu ...
Find out more
The startup AbTx, which specializes in immuno-oncology, aims to tackle the most difficult-to-treat cancers using a breakthrough technology: ...
Find out more
Une rencontre mythique entre ceux qui font la biotech depuis 30 ans et ceux qui vont la faire pour les 30 ans à venir.
Paris 30 June 2026 - 30 June 2026
Details
: Montpellier, France 30 June 2026 - 1 July 2026 Organisateur : MabDesign & MabImprove
Details
Une délégation de la filière régionale BIOVALIANCE réunissant chercheurs, entrepreneurs et start-ups partira à la rencontre des acteurs majeurs des biotechnologies et des thérapies innovantes afin de développer des collaborations et partenariats stratégiques à l’international.
Montréal 4 July 2026 - 10 July 2026 Organisateur : « Tube à Essais » et la Région Bourgogne-Franche-Comté avec accompagnement AER BFC
BIOVALIANCE is the brand of the regional biotherapies and bioproduction sector in Bourgogne-Franche-Comté. Reflecting the complementary nature of the stakeholders involved, it illustrates the region’s specialisation in the design and production of innovative therapies, as well as the supply of bioactivators and industrial equipment.
Jérôme DURAIN, President of the Bourgogne-Franche-Comté Regional Council
*Non-exhaustive list